We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Olympus

Manufactures optical and digital equipment for the healthcare and consumer electronics sectors, including endoscopy a... read more Featured Products: More products

Download Mobile App





Olympus Highlights Surgical Visualization Platform for Future-Proof Endoscopic Surgery

By HospiMedica International staff writers
Posted on 31 Jan 2024

Olympus Corporation (Tokyo, Japan) is showing the latest innovations that redefine possibilities in healthcare, from state-of-the-art imaging technology to breakthrough medical procedures, at Arab Health 2024. More...

At the 49th edition of Arab Health, Olympus is showcasing, amongst others, its latest product launch, the VISERA ELITE III surgical visualization platform - an innovative and open solution that brings together multiple observation modes for future-proof endoscopic surgery. VISERA ELITE III offers various imaging functions, all supported in one system enabling minimally invasive therapies such as laparoscopic colectomy and laparoscopic cholecystectomy. By providing surgeons with multiple observation modes, the all-in-one system supports standardization and increases efficiency in the operating room. Users can also set up customized departmental profiles on VISERA ELITE III for different medical disciplines such as general surgery, urology, gynecology, ENT surgery, and more.

Olympus is also highlighting the POWERSEAL Sealer/Divider which supports the treatment of colon, stomach, lung, and other major types of cancer – but also non-cancer conditions – and can therefore be applied in various medical specialties, from lower to upper gastrointestinal surgery and gynecology, as well as in urology and other areas. Also being highlighted is the iTind, a non-surgical device for the minimally invasive treatment of Benign Prostatic Hyperplasia (BPH). The temporarily implanted nitinol device is inserted in an efficient and straightforward procedure with a short learning curve. Through gentle pressure on the tissue and localized ischemia, the iTind procedure aims to reshape the tissue of the prostatic urethra and the bladder neck. After 5-7 days, the iTind device is removed leaving nothing behind.

In addition, Olympus is showcasing the CELERIS disposable sinus debrider, a single-use microdebrider designed for ENTs who want the power and resection efficiency of a traditional sinus debrider in a convenient single-use solution, without compromising performance or quality. Within its medical portfolio, Olympus is showcasing its most advanced endoscopy system with AI, EVIS X1 which represents a range of new, easy-to-use technologies that aim to revolutionize the way gastrointestinal disorders can be detected, characterized, and treated.

Related Links:
Olympus Corporation


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Mobile X-Ray System
K4W
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
ARAB HEALTH 2024
Copyright © 2000-2025 Globetech Media. All rights reserved.